Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Journal of Autoimmunity|June 1, 1989
Serum IgD levels in mice: effect of strain, age and autoimmune diseaseR F van Vollenhoven, C D Swenson, A Soriano, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1988
The role of immunity to cartilage proteoglycan in adjuvant arthritis. Intravenous injection of bovine proteoglycan enhances adjuvant arthritisR F Van Vollenhoven, A Soriano, P E McCarthy, et al.
The American Journal of Medicine|October 8, 1997
Skeletal status of men with early and late ankylosing spondylitisY S Lee, T Schlotzhauer, S M Ott, et al.
Scandinavian Journal of Rheumatology|June 28, 2019
Association of female sex and positive rheumatoid factor with low serum infliximab and anti-drug antibodies, related to treatment failure in early rheumatoid arthritis: results from the SWEFOT trial populationK Hambardzumyan, C Hermanrud, P Marits, et al.
Annals of the Rheumatic Diseases|November 19, 2008
Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD studyR Fleischmann, J Vencovsky, R F van Vollenhoven, et al.
Lupus|May 23, 2018
Rituximab-mediated late-onset neutropenia in systemic lupus erythematosus - distinct roles of BAFF and APRILI Parodis, F Söder, F Faustini, et al.
The Journal of Rheumatology|August 18, 1999
VH4-34 encoded antibodies in systemic lupus erythematosus: a specific diagnostic marker that correlates with clinical disease characteristicsR F van Vollenhoven, M M Bieber, M J Powell, et al.
Scandinavian Journal of Rheumatology|November 2, 2021
Disease activity in women with ankylosing spondylitis remains higher under Tumour Necrosis Factor inhibitor treatment than in men: a five-year observational studyT Rusman, M T Nurmohamed, S Hoekstra, et al.
Annals of the Rheumatic Diseases|October 13, 2010
Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trialP P Tak, W F Rigby, A Rubbert-Roth, et al.
Scandinavian Journal of Rheumatology|July 28, 2016
Implementation of protocolized tight control and biological dose optimization in daily clinical practice: results of a pilot studyN Lesuis, L M Verhoef, L M Nieboer, et al.
Pageof 8